2025-11-21
From November 17-20, 2025, MEDICA 2025, one of the world's leading medical exhibitions, took place in Düsseldorf, Germany. KHB Group once again made a strong presence, showcasing an integrated suite of diagnostic solutions alongside our subsidiaries Tianlong, Focus Diagnostics, and Technogenetics S.P.A. (TGS).
Together, we demonstrated a comprehensive offering that spans clinical chemistry, immunoassay, molecular diagnostics, POCT, veterinary diagnostics, and food & environmental safety testing, providing end-to-end solutions for a diverse range of applications. The booth attracted hundreds of visitors from around the world, making KHB Group one of the most notable exhibitors at the event.
Strengthening Synergy: A Comprehensive Diagnostic Ecosystem
KHB Group's participation at MEDICA 2025 marked a significant step forward in our global collaboration strategy. By combining the strengths of KHB's chemistry and immunoassay platforms, Tianlong's molecular diagnostics, Focus Diagnostics' veterinary solutions, and TGS's autoimmune diagnostics, we presented a fully integrated ecosystem of solutions. This collaboration bridges traditional testing to precision diagnostics, covering human health, animal diagnostics, and environmental monitoring.
Our long-term partners shared the following feedback during the event:
“KHB continues to deepen integration each year, offering more flexible and regionally customized solutions. The progress is clear.”
Product Highlights: Precision, Automation, and Intelligent Diagnostics
Polaris V150 – Redefining Compact Immunoassay
The Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer stood out as a flagship innovation, attracting strong interest from global visitors.
- Compact design (occupying only 0.36 m2)
- High throughput (150 tests/hour)
- 12 reagent positions, 40 sample positions
- Intelligent features like liquid-level detection, STAT insertion, and automated dilution
MF200 – Revolutionizing Veterinary Diagnostics
The FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer made a strong impact, thanks to its integrated functionality that combines chemistry, coagulation, immunoassay, and electrolytes.
- Requires only 10μL sample volume, ideal for small animals
- Reagents stable at ambient temperatures, reducing operational costs
- Comprehensive reports in 10 minutes, meeting high-throughput needs for medium and large veterinary clinics
?
Rapid Testing + Molecular Confirmation: A Comprehensive Approach
KHB's rapid diagnostic solutions, such as the HIV, HBV, HCV, and syphilis rapid tests, continue to expand. Notably, KHB's HIV Rapid Test is the first in China to receive CE IVDR Class D certification.
By combining rapid screening with Tianlong's molecular diagnostic platforms, KHB Group has developed a complete end-to-end solution for global public health — covering “rapid screening → precise confirmation”.
??
Client Testimonials: Strengthening Partnerships Worldwide
Many long-time users of KHB's chemistry analyzers visited the booth to explore our latest innovations. One European partner shared:
“From the ZY series to the new Polaris series, KHB equipment has always been reliable. The excellent stability allows us to focus on test quality, and the timely after-sales service is invaluable.”
Additionally, a 40-person delegation of domestic distributors attended, highlighting the strong partnership and trust in KHB's products and services. The delegation leader expressed:
?
“With KHB’s comprehensive product range and reliable quality, we are confident in deepening market penetration. This visit was to better understand the full range of new products and prepare for future business expansion.”
?
?
Looking Ahead: Shaping the Future of Diagnostics with a Global Vision
MEDICA 2025 marks another important milestone in KHB Group's global journey. Moving forward, KHB will continue to:
- Increase investment in R&D
- Accelerate innovation and technology upgrades
- Strengthen global regional collaborations
?
With a commitment to innovative, flexible, and reliable solutions, KHB Group is focused on creating a new era of precision diagnostics, healthcare innovation, and global partnerships.